Definium Therapeutics (DFTX) had the highest return between January 1, 2019 and December 31, 2020 by a mid-cap US stock or mid-cap US stock, returning 6,831.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Definium Therapeutics (DFTX) | 1/1/2019 - 12/31/2020 | 6,831.82% |
Enphase Energy (ENPH) | 1/1/2019 - 12/31/2020 | 3,689.85% |
Axsome Therapeutics (AXSM) | 1/1/2019 - 12/31/2020 | 2,799.29% |
Kodiak Sciences (KOD) | 1/1/2019 - 12/31/2020 | 1,980.88% |
Celsius (CELH) | 1/1/2019 - 12/31/2020 | 1,384.07% |
Centrus Energy (LEU) | 1/1/2019 - 12/31/2020 | 1,310.37% |
Ondas (ONDS) | 1/1/2019 - 12/31/2020 | 1,299.43% |
TG Therapeutics (TGTX) | 1/1/2019 - 12/31/2020 | 1,187.62% |
Skeena Resources (SKE) | 1/1/2019 - 12/31/2020 | 1,136.36% |
Immunitybio (IBRX) | 1/1/2019 - 12/31/2020 | 1,090.18% |
Riot Platforms (RIOT) | 1/1/2019 - 12/31/2020 | 1,025.17% |
Galaxy Digital (GLXY) | 1/1/2019 - 12/31/2020 | 968.13% |
Snap (SNAP) | 1/1/2019 - 12/31/2020 | 830.67% |
Magnite (MGNI) | 1/1/2019 - 12/31/2020 | 741.37% |
Nio Inc Class A ADR (NIO) | 1/1/2019 - 12/31/2020 | 695.11% |
Acm Research (ACMR) | 1/1/2019 - 12/31/2020 | 654.41% |
Aura Minerals Inc Common Shares (AUGO) | 1/1/2019 - 12/31/2020 | 632.57% |
Trade Desk (TTD) | 1/1/2019 - 12/31/2020 | 616.07% |
Chord Energy (CHRD) | 1/1/2019 - 12/31/2020 | 591.42% |
Arrowhead Pharmaceuticals (ARWR) | 1/1/2019 - 12/31/2020 | 531% |
Appian (APPN) | 1/1/2019 - 12/31/2020 | 517.49% |
Bilibili (BILI) | 1/1/2019 - 12/31/2020 | 512.29% |
Zai Lab (ZLAB) | 1/1/2019 - 12/31/2020 | 488.95% |
Celldex Therapeutics (CLDX) | 1/1/2019 - 12/31/2020 | 484% |
Peloton Interactive (PTON) | 1/1/2019 - 12/31/2020 | 461.93% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.